Menu Back to Global-Clinical-Trial-Disclosure-and-Data-Transparency-Conference


Clinical trial information transparency is taking on new dimensions. Clinical trial sponsors and academia are facing a host of new registration requirements in the US, EU, and elsewhere. With evolving requirements comes new challenges, creating additional opportunities for knowledge-sharing and necessitating more interaction with peers. This conference will provide critical and timely information relating to global clinical trial disclosure and data transparency from those on the front lines.

This program has been developed in collaboration with the Clinical Trial Disclosure and Data Transparency Community.

Who should attend?

Professionals involved in:
  • Compliance/Legal
  • Clinical trial disclosure
  • Transparency policies and compliance
  • Clinical operations
  • Medical writing, medical affairs, and medical communications
  • Regulatory
  • Publications
  • Biometrics
  • Data management
  • Disclosure
  • Data transparency/data sharing
  • Academia
  • Clinical/Medical Research
  • Patient Advocacy

Learning objectives

  • Discuss best practices to achieve good compliance
  • Assess the operational challenges and considerations in executing Innovative Trial Designs
  • Discuss the interplay between clinical data disclosure and transparency requirements

Program Committee

  • Suzanne  Carlson, MA
    Suzanne Carlson, MA Consultant
    ABSD Associates, LLC, United States
  • Kelly  Coulbourne, MS
    Kelly Coulbourne, MS Director, Clinical Trial Disclosure and Data Transparency
    Arena Pharmaceuticals, United States
  • Patrick  Fawcett
    Patrick Fawcett Information Disclosure Administrator, Office of Research Protections
    University of Pittsburgh, United States
  • Francine  Lane, MBA
    Francine Lane, MBA Vice President, Global Transparency
    Informa, United States
  • Robert  Paarlberg, MS
    Robert Paarlberg, MS Principal
    Paarlberg & Associates LLC, United States
  • Nancy  Williams
    Nancy Williams Associate Director, RSMO Document Publishing Solutions
    Janssen Pharmaceuticals, United States
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
    Independent, Denmark
Load More